Is Microsoft the Best Long-Term AI Play – For Shareholders and the Climate?
Eli Lilly is redefining what scale and impact look like in modern healthcare. Its leadership in weight loss and metabolic disease is driving accelerating growth and exceptional profitability. At the same time, these therapies are improving lives and reducing long term health risks worldwide. For investors, Lilly offers a rare mix of quality, growth, and meaningful impact.
Is Microsoft the Best Long-Term AI Play – For Shareholders and the Climate? Read More







